Resumen
Substance use disorders (SUD) are chronic relapsing medical conditions characterised by compulsive substance seeking and use. They constitute a substantial disease burden globally. Labelling of persons with SUD has created barriers to treatment but there are effective management strategies. The dental profession has embraced reforms designed to address the SUD epidemic by promoting continuing education for practitioners and initiating curriculum changes in dental schools. Screening, Brief Intervention and Referral to Treatment (SBIRT) is an evidence-based model for managing patients with SUD. The use of a formative 1-station Objective Structured Clinical Examination (OSCE) for learning and assessment in SBIRT, operationalised with the MD3 rating scale is presented in this study. In 3 years of implementation, the SBIRT OSCE successfully integrated into the curriculum of the College of Dental Medicine, Columbia University. Mean score of total adherent behaviours was 11.80 (SD =4.23) (range: 2 – 24) and Cronbach's coefficient alpha for across-items reliability in adherent behaviours was 0.66. Adherent behaviours correlated with the global ratings (r = 0.66). Mean of global rating scores were 2.90 (SD =1.01) for collaboration and 2.97 (SD =1.00) for empathy and the global rating scores correlated with each other (r = 0.85). Histograms of global rating scores resembled normal distribution. The 1-station OSCE is a good model for learning about SBIRT. Psychometric analysis was useful in understanding the underlying construct of the MD3 rating scale and supported its reliability, validity and utility in dental education.
Idioma original | English |
---|---|
Páginas (desde-hasta) | 813-828 |
Número de páginas | 16 |
Publicación | European Journal of Dental Education |
Volumen | 25 |
N.º | 4 |
DOI | |
Estado | Published - nov. 2021 |
Financiación
Dr. Odusola is currently a consultant for the American Academy of Addiction Psychiatry (AAAP). Dr. Nunes served as an unpaid consultant to Alkermes, Braeburn‐Camurus, Pear Therapeutics, has received in‐kind medication for studies from Reckitt/Indivior, Alkermes and has received a therapeutic application from Pear Therapeutics for a study. Dr. Levin has received salary support from NYSPI, grant support from SAMSHA and NIH, material and research support for a study from USWorldMeds, is a consultant for Major League Baseball and is on the Scientific Advisory Board of Alkermes and USWorldMeds. Dr. Levin did not personally receive any compensation in the form of cash payments (honoraria/consulting fees/travel reimbursement or meals). Otherwise, we have no financial relationship with the content of this paper. The authors wish to express their gratitude to the staff of the College of Dental Medicine and the Department of Psychiatry, Columbia University and the New York State Psychiatric Institute who gave their time and effort in ensuring the completion of this study. We are especially grateful to Jorge Caccavelli for his contributions to the management of the OSCE. We also wish to acknowledge Drs. Michael J. Devlin and Prantik Saha who were the lead authors of the BCCC.
Financiadores | Número del financiador |
---|---|
Department of Psychiatry | |
SAMSHA | |
USWorldMeds | |
National Institutes of Health | |
National Institute on Drug Abuse | K24DA029647 |
Columbia University | |
New York State Psychiatric Institute |
ASJC Scopus Subject Areas
- Education
- General Dentistry